fasting glutathione intermittent and fasting, fatty acid metabolism reprogramming, neuroimmuno microenvironment: mechanisms and application prospects Combined intermittent fasting and ERK – A 48-hour fast can turn

Human clinical trial data for Dihexa remain limited

Wildenburg G et al

The bonds that give them their structure and function are fragile in ways that most pharmaceuticals arent, as a 2025 review in Protein & Peptide Letters on therapeutic peptide stability documented: heat and environmental exposure during storage and transit break down amino acid bonds, degrading the compound before it reaches the consumer

the parallel fosgonimeton LIFT-AD failure and the pro-proliferative c-Met concern and why hype is not evidence, and sleep, exercise and fuel come first, not a dye or a peptide

Lets Talk!

The peptide market contains significant variability, and bargain hunting often leads to wasted money on inactive products